Post hoc analysis of the ADJUST-T1D RCT in adults with type 1 diabetes and obesity on automated insulin delivery: with semaglutide, total daily insulin fell 22.6% by week 26, driven by bolus insulin; early falls were mainly a direct drug effect, not weight loss.
Secondary analysis
Karakus et al. Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis